VEITHsymposium | VEITH 2023
14.11.2023 – 18.11.2023 // New York (USA)
Imaging in NMD | MYO-MRI 2023
5.11.2023 – 7.11.2023 // Berlin (Germany)
Fast optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo
In this webinar, Dr. Hailong He, Group leader at Technical University of Munich, presents his work on fast high-resolution optoacoustic imaging in human melanoma. He shows how 3D imaging of vascular characteristics in skin lesions could allow diagnostic insights not available by conventional visual inspection.
Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
In this webinar, Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.
iThera Medical reports initiation of fifth clinical site in ongoing study for the non-invasive assessment of inflammatory bowel disease
Munich, DE – Medical device company iThera Medical announces that the fifth site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). […]
iThera Medical leads €1.6m project to develop novel machine learning-assisted optoacoustic imaging of neuromuscular disease
Medical device company iThera Medical announces the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation. Commenced on 01 May 2022, the project aims to develop an innovative new approach to monitor neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image reconstruction assisted by […]
iThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical use
Munich, DE – Medical device company iThera Medical announces successful funding of the Horizon Europe technology innovation project FRONTIER. Under the EIC Accelerator program, Europe’s largest and most selective public funding program for breakthrough innovation projects, the EU will provide €2.5 million grant funding and up to €15 million equity. Through this project, iThera Medical […]
Non-invasive optoacoustic imaging of proteinopathy in mouse models of Alzheimer’s disease
Dr. Ruiqing Ni, group leader at the Institute for Regenerative Medicine, UZH and Institute for Biomedical Engineering, ETH
iThera Medical introduces the world’s first transmission ultrasound system
Imaging device company iThera Medical announces the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems. As the world leader in optoacoustic […]
iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease
Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The chronic condition […]